Related Experiment Videos
Etiologic factors of hypercalcemia in breast cancer
Texas Medicine
|March 1, 1978
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Weekly paclitaxel, carboplatin, cetuximab, and cetuximab, docetaxel, cisplatin, and fluorouracil, followed by local therapy in previously untreated, locally advanced head and neck squamous cell carcinoma.
Annals of oncology : official journal of the European Society for Medical Oncology·2019
Phase II trial of everolimus and erlotinib in patients with platinum-resistant recurrent and/or metastatic head and neck squamous cell carcinoma.
Annals of oncology : official journal of the European Society for Medical Oncology·2015
A randomized phase II study of the MEK1/MEK2 inhibitor trametinib (GSK1120212) compared with docetaxel in KRAS-mutant advanced non-small-cell lung cancer (NSCLC)†.
Annals of oncology : official journal of the European Society for Medical Oncology·2015
A randomized, double-blind, phase II study of erlotinib with or without sunitinib for the second-line treatment of metastatic non-small-cell lung cancer (NSCLC).
Annals of oncology : official journal of the European Society for Medical Oncology·2013
Defining biomarkers to predict sensitivity to PI3K/Akt/mTOR pathway inhibitors in breast cancer.
Cancer treatment reviews·2012
Commentary: This Is Not a Drill.
Texas medicine·2021
Talk to Patients About: Vaccine Adverse Event Reporting System (VAERS).
Texas medicine·2021
Obstacles to Clear.
Texas medicine·2021
Integrative Analysis of IGFL2‑AS1 and BRCA1 Expression in Esophageal Cancer: An Experimental and Bioinformatics‑Based Study.
Iranian biomedical journal·2026
SMC1A drives radioresistance in lung squamous cell carcinoma through the ILF2/RNF2 axis.
Biochimica et biophysica acta. Molecular basis of disease·2026
The fear in the waiting room.
Med (New York, N.Y.)·2026
Dual-Targeted Inhibition of PAR2 Endosomal Signaling in Synoviocytes and Nociceptors Attenuates Osteoarthritis Pain.
Nanomaterials (Basel, Switzerland)·2026
Training clinician-scientists in Canada: The CANTRAIN clinical fellows program.
Clinical and investigative medicine. Medecine clinique et experimentale·2026